About BioChain
BioChain is a company based in Hayward (United States) founded in 1994.. BioChain has raised $7.34 million across 2 funding rounds from investors including HHS and Ascendent Capital Partners. BioChain offers products and services including Biospecimens, Extraction Kits, Automated Instruments, and Custom Services. BioChain operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
- Headquarter Hayward, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biochain Institute, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.34 M (USD)
in 2 rounds
-
Latest Funding Round
$7.34 M (USD), Private Equity Round
Nov 11, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioChain
BioChain offers a comprehensive portfolio of products and services, including Biospecimens, Extraction Kits, Automated Instruments, and Custom Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-quality tissues and samples for research and testing purposes
Kits for DNA, RNA, and protein extraction in laboratories
Devices for automated sample preparation and analysis
Tailored biospecimen procurement and analysis for clients
Unlock access to complete
Unlock access to complete
Funding Insights of BioChain
BioChain has successfully raised a total of $7.34M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $7.34 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Private Equity Round — $7.3M
-
First Round
First Round
(05 May 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2016 | Amount | Private Equity Round - BioChain | Valuation | Ascendent Capital Partners |
|
| May, 2008 | Amount | Grant - BioChain | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioChain
BioChain has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Ascendent Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioChain
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioChain
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biochain Comparisons
Competitors of BioChain
BioChain operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biochain
Frequently Asked Questions about BioChain
When was BioChain founded?
BioChain was founded in 1994 and raised its 1st funding round 14 years after it was founded.
Where is BioChain located?
BioChain is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Who is the current CEO of BioChain?
Grace Tian is the current CEO of BioChain.
Is BioChain a funded company?
BioChain is a funded company, having raised a total of $7.34M across 2 funding rounds to date. The company's 1st funding round was a Grant of $200.44K, raised on May 05, 2008.
What does BioChain do?
Provider of products and services for clinical diagnosis, genomics, and proteomics. The products (markers, kits, reagents) for DNARNA and proteins related research. It provides kits for sequencing, enzyme assays, PCR, immunodiagnostics. Also offers an extensive collection of tissue blocks, slides, frozen arrays, and FFPE arrays for human normal, diseased, and tumor tissue types. It provides custom services such as clinical samples collection, extraction and purification, tissue section and array, and others.
Who are the top competitors of BioChain?
BioChain's top competitors include Abcam, Sino Biological and Meridian Bioscience.
What products or services does BioChain offer?
BioChain offers Biospecimens, Extraction Kits, Automated Instruments, and Custom Services.
Who are BioChain's investors?
BioChain has 2 investors. Key investors include HHS, and Ascendent Capital Partners.